Abnormal prolactin responsivity to dopaminergic suppression in hyperprolactinemic patients
- PMID: 7315858
- DOI: 10.1016/0002-9343(81)90314-4
Abnormal prolactin responsivity to dopaminergic suppression in hyperprolactinemic patients
Similar articles
-
Hyperprolactinemic amenorrhea in a woman with a craniopharyngioma: persisting amenorrhea after prolactin suppression with bromocriptine.Am J Obstet Gynecol. 1983 Sep 1;147(1):109-11. doi: 10.1016/0002-9378(83)90097-2. Am J Obstet Gynecol. 1983. PMID: 6614079 No abstract available.
-
Defective dopaminergic regulation of prolactin secretion in a rat pituitary tumour cell line.Nature. 1977 Apr 14;266(5603):640-1. doi: 10.1038/266640a0. Nature. 1977. PMID: 859630 No abstract available.
-
Physiologic concentrations of dopamine fail to suppress prolactin secretion in patients with idiopathic hyperprolactinemia or prolactinomas.Am J Obstet Gynecol. 1985 Mar 1;151(5):651-5. doi: 10.1016/0002-9378(85)90157-7. Am J Obstet Gynecol. 1985. PMID: 3976764
-
Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas.Nature. 1979 Mar 15;278(5701):252-4. doi: 10.1038/278252a0. Nature. 1979. PMID: 423973 No abstract available.
-
[Recent advances in immunoassay. Technical progress and its application to laboratory medicine].Yakugaku Zasshi. 1987 Oct;107(10):739-50. doi: 10.1248/yakushi1947.107.10_739. Yakugaku Zasshi. 1987. PMID: 3326930 Review. Japanese. No abstract available.
Cited by
-
Hyperprolactinemia: neuroendocrine and diagnostic aspects.J Endocrinol Invest. 1989 Oct;12(9):653-68. doi: 10.1007/BF03350030. J Endocrinol Invest. 1989. PMID: 2685096 Review. No abstract available.
-
Prolactin-secreting pituitary adenomas.West J Med. 1983 Nov;139(5):663-72. West J Med. 1983. PMID: 6659490 Free PMC article.
-
More on nomifensine.J Endocrinol Invest. 1985 Apr;8(2):183-4. doi: 10.1007/BF03350679. J Endocrinol Invest. 1985. PMID: 4031386 No abstract available.
-
Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.J Endocrinol Invest. 1985 Feb;8(1):35-40. doi: 10.1007/BF03350635. J Endocrinol Invest. 1985. PMID: 3989236
-
Effect of the new ergot derivative terguride on plasma PRL and GH levels in patients with pathological hyperprolactinemia or acromegaly.J Endocrinol Invest. 1985 Apr;8(2):147-51. doi: 10.1007/BF03350671. J Endocrinol Invest. 1985. PMID: 4031381
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical